195 related articles for article (PubMed ID: 34957765)
21. Catecholamine-induced cardiomyopathy improvement after para-aortic paraganglioma resection: a case report.
Ranjbar M; Amin A; Totonchi Z; Ghaemmaghami Z; Jalilian Z; Hesami M; Givtaj N; Jadbabaei AN; Divanbeigi I; Mazloomfard MM
ESC Heart Fail; 2022 Feb; 9(1):213-218. PubMed ID: 34967117
[TBL] [Abstract][Full Text] [Related]
22. Seizures in patients with a phaeochromocytoma/paraganglioma (PPGL): A review of clinical cases and postulated pathological mechanisms.
Li Y; Zhang B
Rev Neurol (Paris); 2019 Oct; 175(9):495-505. PubMed ID: 31133278
[TBL] [Abstract][Full Text] [Related]
23. Pheochromocytoma-induced cardiogenic shock.
Louis S; Selma H; Nicolas T
Acta Chir Belg; 2023 Oct; 123(5):573-576. PubMed ID: 35583372
[TBL] [Abstract][Full Text] [Related]
24. Phaeochromocytoma associated with cardiomyopathy and leukocytoclastic vasculitis in a dog.
Poldy J; Gelendi S; Starybrat D; Del-Pozo J
J Comp Pathol; 2023 Jul; 204():30-34. PubMed ID: 37329661
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular manifestations of phaeochromocytoma.
Prejbisz A; Lenders JW; Eisenhofer G; Januszewicz A
J Hypertens; 2011 Nov; 29(11):2049-60. PubMed ID: 21826022
[TBL] [Abstract][Full Text] [Related]
26. [Cardiomyopathy: first clinical manifestation of a pheochromocytoma--case report].
Lopes A; Sousa C; Correia MJ; Júnior C; Rocha J; Pinto F
Rev Port Cardiol; 2010 Jun; 29(6):1065-9. PubMed ID: 20967964
[TBL] [Abstract][Full Text] [Related]
27. Pheochromocytoma causing cardiomyopathy, ischemic stroke and acute arterial thrombosis: a case report and review of the literature.
Vindenes T; Crump N; Casenas R; Wood K
Conn Med; 2013 Feb; 77(2):95-8. PubMed ID: 23513638
[TBL] [Abstract][Full Text] [Related]
28. Lesson of the month 2: Catecholamine-induced cardiomyopathy - pitfalls in diagnosis and medical management.
Mamoojee Y; Arham M; Elsaify W; Nag S
Clin Med (Lond); 2016 Apr; 16(2):201-3. PubMed ID: 27037396
[TBL] [Abstract][Full Text] [Related]
29. A rare cause of cardiogenic shock: catecholamine cardiomyopathy of pheochromocytoma.
Imperadore F; Azzolini M; Piscioli F; Pusiol T; Capitanio A; Vergara G
Ital Heart J; 2002 Jun; 3(6):375-8. PubMed ID: 12116803
[TBL] [Abstract][Full Text] [Related]
30. Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors.
März J; Kurlbaum M; Roche-Lancaster O; Deutschbein T; Peitzsch M; Prehn C; Weismann D; Robledo M; Adamski J; Fassnacht M; Kunz M; Kroiss M
Front Endocrinol (Lausanne); 2021; 12():722656. PubMed ID: 34557163
[TBL] [Abstract][Full Text] [Related]
31. Pheochromocytoma: An overlooked reversible cause of heart failure with reduced ejection fraction.
Çoner A; Özyıldız AG
Turk Kardiyol Dern Ars; 2021 Sep; 49(6):501-505. PubMed ID: 34523598
[TBL] [Abstract][Full Text] [Related]
32. Coronary artery myointimal dysplasia in patients with pheochromocytoma-possible causal relationship: pathophysiology and clinical implication with reference to Takotsubo cardiomyopathy and spontaneous coronary dissection.
Chow LTC; Chow MBCY
Cardiovasc Pathol; 2018; 37():45-53. PubMed ID: 30342321
[TBL] [Abstract][Full Text] [Related]
33. Takotsubo-like cardiomyopathy in pheochromocytoma.
Agarwal V; Kant G; Hans N; Messerli FH
Int J Cardiol; 2011 Dec; 153(3):241-8. PubMed ID: 21474192
[TBL] [Abstract][Full Text] [Related]
34. [A rare case of recurrent myocarditis revealing pheochromocytoma].
Bouamoud A; Zaim C; Kerrouani W; Haddioui ME; Bouissou K; Bouazaze M; Amri R
Ann Cardiol Angeiol (Paris); 2024 Jun; 73(3):101768. PubMed ID: 38788259
[TBL] [Abstract][Full Text] [Related]
35. Clinical Presentation and Treatment Outcomes of Children and Adolescents With Pheochromocytoma and Paraganglioma in a Single Center in Korea.
Park H; Kim MS; Lee J; Kim JH; Jeong BC; Lee S; Lee SK; Cho SY; Jin DK
Front Endocrinol (Lausanne); 2020; 11():610746. PubMed ID: 33584544
[TBL] [Abstract][Full Text] [Related]
36. [Uncommon cardiac manifestations disclosing pheochromocytoma. Apropos of 3 cases].
Choisne C; Cottin Y; André F; Arnould L; Cougard P; Michel F; Viard H; Louis P; Wolf JE
Ann Cardiol Angeiol (Paris); 1994 Jun; 43(6):331-4. PubMed ID: 8085772
[TBL] [Abstract][Full Text] [Related]
37. The Role for Metyrosine in the Treatment of Patients With Pheochromocytoma and Paraganglioma.
Gruber LM; Jasim S; Ducharme-Smith A; Weingarten T; Young WF; Bancos I
J Clin Endocrinol Metab; 2021 May; 106(6):e2393-e2401. PubMed ID: 33693908
[TBL] [Abstract][Full Text] [Related]
38. Pheochromocytomas and Paragangliomas.
Tevosian SG; Ghayee HK
Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
[TBL] [Abstract][Full Text] [Related]
39. [Clinical profile of pheochromocytoma and paraganglioma with normal plasma free metanephrines].
Liu L; Tian J; Wu K; Gao Y; Zhang Z; Zhang JQ; Guo XH
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 52(4):614-620. PubMed ID: 32773788
[TBL] [Abstract][Full Text] [Related]
40. Genetic biomarkers of life-threatening pheochromocytoma-induced cardiomyopathy.
Amar J; Brunel J; Cardot Bauters C; Jacques V; Delmas C; Odou MF; Savagner F
Endocr Relat Cancer; 2022 Apr; 29(5):267-272. PubMed ID: 35258481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
